Table 1.
General functions | Specific involvement | Signs/symptoms and altered metabolisms associated with hypomagnesemia* |
---|---|---|
Enzymatic activities: functioning as substrate or direct enzyme activation | Kinases, ATPases or GTPases, cyclases, phosphofructokinase, creatine kinase, 5-phosphoribosyl-pyrophosphate synthetase, adenylate cyclase, Na+-K+-ATPase | Altered glucose metabolism, electrolyte imbalances (hypokalemia, hypocalcemia), osteoporosis, enhanced digoxin sensitivity, enhanced apoptosis, arrhythmias, atherosclerosis |
Membrane function | Cell adhesion, transmembrane electrolyte flux | Arrhythmias: atrial tachycardia and fibrillation, supraventricular and ventricular arrhythmias, Torsade de pointes, rhabdomyolysis, hemolysis, myocardial infarction |
Calcium antagonist | Neuromuscular function | Neuromuscular hyperexcitability: tremors, fasciculation, tetany, convulsions, neuropsychiatric changes, eg, apathy, depression, psychosis, vertigo, nystagmus, athetoid movements and choreiform movements, migraine, asthma (reactive airways), impaired exercise performance, electrolyte imbalances (hypokalemia, hypocalcemia), hypertension, atherosclerosis |
Structural function, ion complex formation | Proteins, polyribosomes, nucleic acids, multiple enzyme complexes, mitochondria, ion complexes | Enhanced apoptosis, osteoporosis, kidney stones |
Notes: Copyright © 2003. Australasian Association of Clinical Biochemists. Adapted from Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24(2):47–66.3
Signs and symptoms are listed based on possible and/or presumed mechanisms of hypomagnesemia-induced defective structural or physiological functions. Many signs and symptoms are multifactorial, not fully understood, and beyond the scope of the current paper.
Abbreviations: ATPase, adenosine triphosphatase; GTPase, guanosine triphosphatase; Na+-K+-ATPase, sodium-potassium adenosine triphosphatase.